Under acidic conditions (e.g., brain ischemia, hypoxia, or AD), legumain can translocate from neuronal lysosomes into the cytoplasm, where it cleaves I2PP2A (also known as SET). The gene discussed is LGMN; the disease is Alzheimer disease.